stromelysin inhibitors (Pharmacia & Upjohn)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namestromelysin inhibitors (Pharmacia & Upjohn)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase 3 inhibitors
TargetsMatrix metalloproteinase 3
Therapy Area/IndicationsConnective Tissue DiseasesNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmacia & Upjohn
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmacia & Upjohn
Active IndicationsN/A
Inactive IndicationsConnective Tissue DiseasesNeoplasm Metastasis

Other Information

ATC CodeN/A
Related LinksN/A